I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 3 studies | 20% ± 0% | |
| epithelial cell | 3 studies | 31% ± 16% | |
| glutamatergic neuron | 3 studies | 36% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 3 studies | 20% ± 0% | |
| epithelial cell | 3 studies | 31% ± 16% | |
| glutamatergic neuron | 3 studies | 36% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 3874.59 | 226 / 226 | 100% | 62.43 | 406 / 406 |
| prostate | 100% | 4221.29 | 245 / 245 | 100% | 54.51 | 502 / 502 |
| kidney | 100% | 3590.42 | 89 / 89 | 100% | 84.70 | 898 / 901 |
| lung | 100% | 5019.12 | 578 / 578 | 99% | 59.40 | 1146 / 1155 |
| uterus | 100% | 4077.22 | 170 / 170 | 99% | 81.00 | 455 / 459 |
| breast | 100% | 4382.23 | 459 / 459 | 99% | 52.36 | 1108 / 1118 |
| brain | 99% | 3300.93 | 2610 / 2642 | 100% | 71.18 | 705 / 705 |
| bladder | 100% | 3308.48 | 21 / 21 | 99% | 77.59 | 497 / 504 |
| thymus | 100% | 2496.46 | 652 / 653 | 98% | 43.50 | 595 / 605 |
| skin | 99% | 1955.14 | 1799 / 1809 | 99% | 68.69 | 465 / 472 |
| esophagus | 100% | 2720.35 | 1441 / 1445 | 97% | 40.02 | 178 / 183 |
| intestine | 100% | 3087.24 | 966 / 966 | 96% | 40.80 | 508 / 527 |
| ovary | 100% | 1828.93 | 180 / 180 | 96% | 43.21 | 414 / 430 |
| stomach | 99% | 2297.14 | 356 / 359 | 97% | 40.94 | 277 / 286 |
| adrenal gland | 100% | 2721.22 | 257 / 258 | 95% | 43.68 | 218 / 230 |
| pancreas | 85% | 1019.36 | 280 / 328 | 99% | 82.19 | 176 / 178 |
| adipose | 100% | 4084.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 89.33 | 29 / 29 |
| spleen | 100% | 5151.48 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 90.12 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.09 | 1 / 1 |
| blood vessel | 100% | 2358.57 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 2545.91 | 852 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 37.88 | 79 / 80 |
| peripheral blood | 98% | 3762.56 | 909 / 929 | 0% | 0 | 0 / 0 |
| muscle | 97% | 1836.76 | 778 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008203 | Biological process | cholesterol metabolic process |
| GO_0006953 | Biological process | acute-phase response |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0042157 | Biological process | lipoprotein metabolic process |
| GO_0006869 | Biological process | lipid transport |
| GO_0060135 | Biological process | maternal process involved in female pregnancy |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0008035 | Molecular function | high-density lipoprotein particle binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008289 | Molecular function | lipid binding |
| Gene name | APOL2 |
| Protein name | Apolipoprotein L2 Apolipoprotein L2 (Apolipoprotein L-II) (ApoL-II) |
| Synonyms | |
| Description | FUNCTION: May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles. |
| Accessions | Q9BQE5 ENST00000358502.10 ENST00000451256.6 ENST00000249066.10 ENST00000529194.5 ENST00000454728.5 J3KQL8 E9PM95 B0QYK8 |
